-
1
-
-
34648819361
-
Animal models of Parkinson's disease: Similarities and differences between the disease and models
-
Hattori N, Sato S. Animal models of Parkinson's disease: Similarities and differences between the disease and models. Neuropathology 2007; 27:479-483.
-
(2007)
Neuropathology
, vol.27
, pp. 479-483
-
-
Hattori, N.1
Sato, S.2
-
2
-
-
0036789082
-
Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice
-
Bolin LM, Strycharska-Orczyk I, Murray R, Langston JW, Di Monte D. Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice. J Neurochem 2002; 83:167-175.
-
(2002)
J Neurochem
, vol.83
, pp. 167-175
-
-
Bolin, L.M.1
Strycharska-Orczyk, I.2
Murray, R.3
Langston, J.W.4
Di Monte, D.5
-
3
-
-
77956198871
-
Mitochondria and the link between Neuroinflammation and Neurodegeneration
-
Di Filippo M, Chiasserini D, Tozzi A, Picconi B, Calabresi P. Mitochondria and the link between Neuroinflammation and Neurodegeneration. J Alzheimers Dis 2010; 20:S369-379.
-
(2010)
J Alzheimers Dis
, vol.20
, pp. 369-379
-
-
Di Filippo, M.1
Chiasserini, D.2
Tozzi, A.3
Picconi, B.4
Calabresi, P.5
-
4
-
-
0023789193
-
Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
-
McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988;38:1285-1291
-
(1988)
Neurology
, vol.38
, pp. 1285-1291
-
-
McGeer, P.L.1
Itagaki, S.2
Boyes, B.E.3
McGeer, E.G.4
-
5
-
-
35348966882
-
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
-
Tansey MG, McCoy MK, Frank-Cannon TC. Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol 2007; 208:1-25.
-
(2007)
Exp Neurol
, vol.208
, pp. 1-25
-
-
Tansey, M.G.1
McCoy, M.K.2
Frank-Cannon, T.C.3
-
6
-
-
34249026320
-
Non-steroidal anti-inflammatory drugs in Parkinson's disease
-
Esposito E, Di Matteo V, Benigno A, Pierucci M, Crescimanno G, Di Giovanni G. Non-steroidal anti-inflammatory drugs in Parkinson's disease. Exp Neurol 2007; 205:295-312.
-
(2007)
Exp Neurol
, vol.205
, pp. 295-312
-
-
Esposito, E.1
Di Matteo, V.2
Benigno, A.3
Pierucci, M.4
Crescimanno, G.5
Di Giovanni, G.6
-
7
-
-
79954603165
-
Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease
-
Manthripragada AD, Schernhammer ES, Qiu J, Friis S, Wermuth L, Olsen JH, et al. Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease. Neuroepidemiology 2011; 36:155-161.
-
(2011)
Neuroepidemiology
, vol.36
, pp. 155-161
-
-
Manthripragada, A.D.1
Schernhammer, E.S.2
Qiu, J.3
Friis, S.4
Wermuth, L.5
Olsen, J.H.6
-
8
-
-
33750373343
-
Role of cytokines in inflammatory process in Parkinson's disease
-
Sawada M, Imamura K, Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. J Neural Transm Suppl 2006; 70:373-381.
-
(2006)
J Neural Transm Suppl
, vol.70
, pp. 373-381
-
-
Sawada, M.1
Imamura, K.2
Nagatsu, T.3
-
9
-
-
38449109568
-
Neuroinflammation in Parkinson's disease: Is there sufficient evidence for mechanism-based interventional therapy?
-
Tansey MG, Frank-Cannon TC, McCoy MK, Lee JK, Martinez TN, McAlpine FE, et al. Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy? Front Biosci 2008; 13:709-717.
-
(2008)
Front Biosci
, vol.13
, pp. 709-717
-
-
Tansey, M.G.1
Frank-Cannon, T.C.2
McCoy, M.K.3
Lee, J.K.4
Martinez, T.N.5
McAlpine, F.E.6
-
10
-
-
0034525420
-
Changes in cytokines and neurotrophins in Parkinson's disease
-
Nagatsu T, Mogi M, Ichinose H, Togari A. Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm Suppl 2000; 60:277-290.
-
(2000)
J Neural Transm
, Issue.SUPPL. 60
, pp. 277-290
-
-
Nagatsu, T.1
Mogi, M.2
Ichinose, H.3
Togari, A.4
-
11
-
-
46749085399
-
Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNF_, and INF_ concentrations are elevated in patients with atypical and idiopathic parkinsonism
-
Brodacki B, Staszewski J, Toczyłowska B, Kozłowska E, Drela N, Chalimoniuk M, et al. Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNF_, and INF_ concentrations are elevated in patients with atypical and idiopathic parkinsonism. Neurosci Lett 2008; 441:158-162.
-
(2008)
Neurosci Lett
, vol.441
, pp. 158-162
-
-
Brodacki, B.1
Staszewski, J.2
Toczyłowska, B.3
Kozłowska, E.4
Drela, N.5
Chalimoniuk, M.6
-
12
-
-
70349466534
-
Effects of IL-6 secreted from astrocytes on the survival of dopaminergic neurons in lipopolysaccharide-induced inflammation
-
Li XZ, Bai LM, Yang YP, Luo WF, Hu WD, Chen JP, et al. Effects of IL-6 secreted from astrocytes on the survival of dopaminergic neurons in lipopolysaccharide-induced inflammation. Neurosci Res Suppl 2009; 65:252-258.
-
(2009)
Neurosci Res Suppl
, vol.65
, pp. 252-258
-
-
Li, X.Z.1
Bai, L.M.2
Yang, Y.P.3
Luo, W.F.4
Hu, W.D.5
Chen, J.P.6
-
13
-
-
33750373343
-
Role of cytokines in inflammatory process in Parkinson's disease
-
Sawada M, Imamura K, Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. J Neural Transm 2006; 70:373-381.
-
(2006)
J Neural Transm
, vol.70
, pp. 373-381
-
-
Sawada, M.1
Imamura, K.2
Nagatsu, T.3
-
14
-
-
77949690052
-
Buspirone improves haloperidol-induced Parkinson disease in mice through 5-HT1A receptors
-
Nayebi MA, Sheidaei H. Buspirone improves haloperidol-induced Parkinson disease in mice through 5-HT1A receptors. Daru 2010; 18:41-45.
-
(2010)
Daru
, vol.18
, pp. 41-45
-
-
Nayebi, M.A.1
Sheidaei, H.2
-
15
-
-
69549126673
-
Serotonin and Parkinson's disease: On movement, mood, and madness
-
Fox SH, Chuang R, Brotchie JM. Serotonin and Parkinson's disease: On movement, mood, and madness. Mov Disord 2009; 24:1255-1266.
-
(2009)
Mov Disord
, vol.24
, pp. 1255-1266
-
-
Fox, S.H.1
Chuang, R.2
Brotchie, J.M.3
-
16
-
-
80052834174
-
The serotonergic system in Parkinson's disease
-
Huot P, Fox SH, Brotchie JM. The serotonergic system in Parkinson's disease. Prog Neurobiol 2011; 95:163-212.
-
(2011)
Prog Neurobiol
, vol.95
, pp. 163-212
-
-
Huot, P.1
Fox, S.H.2
Brotchie, J.M.3
-
17
-
-
34247578592
-
Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: Implications for treating Parkinson's disease
-
Mignon L, Wolf WA. Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease. Psychopharmacology (Berl) 2007; 192:49-59.
-
(2007)
Psychopharmacology (Berl)
, vol.192
, pp. 49-59
-
-
Mignon, L.1
Wolf, W.A.2
-
18
-
-
0034615164
-
Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain
-
Riad M, Garcia S, Watkins KC, Jodoin N, Doucet E, Langlois X, et al. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neural. 2000; 417:181-194.
-
(2000)
J Comp Neural.
, vol.417
, pp. 181-194
-
-
Riad, M.1
Garcia, S.2
Watkins, K.C.3
Jodoin, N.4
Doucet, E.5
Langlois, X.6
-
19
-
-
0035960558
-
Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models
-
Bibbiani F, Oh JD, Chase TN. Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models. Neurology 2001; 57:1829-1834.
-
(2001)
Neurology
, vol.57
, pp. 1829-1834
-
-
Bibbiani, F.1
Oh, J.D.2
Chase, T.N.3
-
20
-
-
0032586748
-
Agonist stimulation of the serotonin1A receptor causes suppression of anoxia-induced apoptosis via mitogen-activated protein kinase in neuronal HN2-5 cells
-
Adayev T, El-Sherif Y, Barua M, Penington NJ, Banerjee P. Agonist stimulation of the serotonin1A receptor causes suppression of anoxia-induced apoptosis via mitogen-activated protein kinase in neuronal HN2-5 cells. J Neurochem 1999; 72:1489-1496.
-
(1999)
J Neurochem
, vol.72
, pp. 1489-1496
-
-
Adayev, T.1
El-Sherif, Y.2
Barua, M.3
Penington, N.J.4
Banerjee, P.5
-
21
-
-
42449095441
-
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
-
Anisman H, Merali Z, Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 2008; 85:1-74.
-
(2008)
Prog Neurobiol
, vol.85
, pp. 1-74
-
-
Anisman, H.1
Merali, Z.2
Hayley, S.3
-
22
-
-
34249779530
-
Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, et al. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurosci Res 2007; 85:1752-1761.
-
(2007)
J Neurosci Res
, vol.85
, pp. 1752-1761
-
-
Sawada, H.1
Hishida, R.2
Hirata, Y.3
Ono, K.4
Suzuki, H.5
Muramatsu, S.6
-
23
-
-
45449100715
-
Cytokines disrupt intracellular patterns of Parkinson's disease-associated proteins alpha-synuclein, tau and ubiquitin in cultured glial cells
-
Bick RJ, Poindexter BJ, Kott MM, Liang YA, Dinh K, Kaur B, et al. Cytokines disrupt intracellular patterns of Parkinson's disease-associated proteins alpha-synuclein, tau and ubiquitin in cultured glial cells. Brain Res 2008; 1217: 203-212.
-
(2008)
Brain Res
, vol.1217
, pp. 203-212
-
-
Bick, R.J.1
Poindexter, B.J.2
Kott, M.M.3
Liang, Y.A.4
Dinh, K.5
Kaur, B.6
-
25
-
-
80053373365
-
Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats
-
Mahmoudi J, Nayebi AM, Samini M, Reyhani-Rad S, Babapour V. Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats. Pharmacol Rep 2011; 63:908-914.
-
(2011)
Pharmacol Rep
, vol.63
, pp. 908-914
-
-
Mahmoudi, J.1
Nayebi, A.M.2
Samini, M.3
Reyhani-Rad, S.4
Babapour, V.5
-
26
-
-
34447532344
-
The differential effects of 5-HT1A receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat
-
Dupre KB, Eskow KL, Negron G, Bishop C. The differential effects of 5-HT1A receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat. Brain Res 2007; 1158:135-143.
-
(2007)
Brain Res
, vol.1158
, pp. 135-143
-
-
Dupre, K.B.1
Eskow, K.L.2
Negron, G.3
Bishop, C.4
-
27
-
-
0034010268
-
Regulation of extracellular concentrations of 5-Hydroxytryptamine (5-HT) in mouse striatum by 5-HT1A and 5-HT1B receptors
-
Knobelman DA, Kung HF, Lucki I. Regulation of extracellular concentrations of 5-Hydroxytryptamine (5-HT) in mouse striatum by 5-HT1A and 5-HT1B receptors. J Pharmacol Exp Ther 2000; 292:1111-1117.
-
(2000)
J Pharmacol Exp Ther
, vol.292
, pp. 1111-1117
-
-
Knobelman, D.A.1
Kung, H.F.2
Lucki, I.3
-
28
-
-
0037370191
-
5-Hydroxytryptamine 1A receptor activation protects against N-methyl-D-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures
-
Madhavan L, Freed WJ, Anantharam V, Kanthasamy AG. 5-Hydroxytryptamine 1A receptor activation protects against N-methyl-D-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures. J Pharmacol Exp Ther 2003; 304:913-923.
-
(2003)
J Pharmacol Exp Ther
, vol.304
, pp. 913-923
-
-
Madhavan, L.1
Freed, W.J.2
Anantharam, V.3
Kanthasamy, A.G.4
-
29
-
-
56249141071
-
Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat
-
Dupre KB, Eskow KL, Barnum CJ, Bishop C. Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat. Neuropharmacology 2008; 55:1321-1328.
-
(2008)
Neuropharmacology
, vol.55
, pp. 1321-1328
-
-
Dupre, K.B.1
Eskow, K.L.2
Barnum, C.J.3
Bishop, C.4
-
30
-
-
33745144987
-
5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease
-
Bezard E, Gerlach I, Moratalla R, Gross CE, Jork R. 5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease. Neurobiol Dis 2006; 23:77-86.
-
(2006)
Neurobiol Dis
, vol.23
, pp. 77-86
-
-
Bezard, E.1
Gerlach, I.2
Moratalla, R.3
Gross, C.E.4
Jork, R.5
-
31
-
-
0035728258
-
Multiplicity of mechanisms of serotonin receptor signal transduction
-
Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, et al. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 2001; 92:179-212.
-
(2001)
Pharmacol Ther
, vol.92
, pp. 179-212
-
-
Raymond, J.R.1
Mukhin, Y.V.2
Gelasco, A.3
Turner, J.4
Collinsworth, G.5
Gettys, T.W.6
-
32
-
-
78149468157
-
8-OH-DPAT prevents morphine-induced apoptosis in rat dorsal raphe nucleus: A possible mechanism for attenuating morphine tolerance
-
Charkhpour M, Nayebi AR, Doustar Y, Hassanzadeh K. 8-OH-DPAT prevents morphine-induced apoptosis in rat dorsal raphe nucleus: A possible mechanism for attenuating morphine tolerance. Anesth Analg 2010; 111:1316-1321.
-
(2010)
Anesth Analg
, vol.111
, pp. 1316-1321
-
-
Charkhpour, M.1
Nayebi, A.R.2
Doustar, Y.3
Hassanzadeh, K.4
-
33
-
-
0036324240
-
Parkinson's disease: Changes in apoptosis-related factors suggesting possible gene therapy
-
Nagatsu T. Parkinson's disease: changes in apoptosis-related factors suggesting possible gene therapy. J Neural Transm 2009; 109:731-745.
-
(2009)
J Neural Transm
, vol.109
, pp. 731-745
-
-
Nagatsu, T.1
-
34
-
-
33847759064
-
Systemic LPS Causes Chronic Neuroinflammation and Progressive Neurodegeneration
-
Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, et al. Systemic LPS Causes Chronic Neuroinflammation and Progressive Neurodegeneration. Glia 2007; 55:453-462.
-
(2007)
Glia
, vol.55
, pp. 453-462
-
-
Qin, L.1
Wu, X.2
Block, M.L.3
Liu, Y.4
Breese, G.R.5
Hong, J.S.6
-
36
-
-
62549133546
-
Neuroinflammation in Parkinson's disease: A target for neuroprotection?
-
Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 2009; 8:382-397.
-
(2009)
Lancet Neurol
, vol.8
, pp. 382-397
-
-
Hirsch, E.C.1
Hunot, S.2
-
37
-
-
16344382456
-
Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains
-
Imamura K, Hishikawa N, Ono K, Suzuki H, Sawada M, Nagatsu T, et al. Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains. Acta Neuropathol 2005; 109:141-150.
-
(2005)
Acta Neuropathol
, vol.109
, pp. 141-150
-
-
Imamura, K.1
Hishikawa, N.2
Ono, K.3
Suzuki, H.4
Sawada, M.5
Nagatsu, T.6
-
38
-
-
42649084052
-
The role of interleukin-1 in neuroinflammation and Alzheimer disease: An evolving perspective
-
Shaftel SS, Griffin WS, O'Banion MK. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 2008; 5:7.
-
(2008)
J Neuroinflammation
, vol.5
, pp. 7
-
-
Shaftel, S.S.1
Griffin, W.S.2
O'Banion, M.K.3
|